image

SEC Filings

We are focused on the rapid design and development of new medicines based on breakthroughs in cancer research.
Filing date Description Form View

Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy

DRS View HTML

Report of unscheduled material events or corporate event

8-K View HTML

Quarterly report which provides a continuing view of a company's financial position

10-Q EX-101.INS - XBRL INSTANCE DOCUMENT View HTML

Report of unscheduled material events or corporate event

8-K View HTML

Filing by person(s) reporting owned shares of common stock in a public company >5%

SC 13D View HTML

Filing by person(s) reporting owned shares of common stock in a public company >5%

SC 13D View HTML

Statement of changes in beneficial ownership of securities

4 View HTML

Statement of changes in beneficial ownership of securities

4 View HTML

Statement of changes in beneficial ownership of securities

4 View HTML

Amendment to a previously filed 4

4/A View HTML

Data provided by Kaleidoscope.